APO N150 APO N150 Pill: red, capsule/oblong
The pill with imprint APO N150 APO N150 (Red, Capsule/Oblong, 0mm) has been identified as Nilotinib 150 mg and is used for Chronic Myelogenous Leukemia. It belongs to the drug class BCR-ABL tyrosine kinase inhibitors and is not a controlled substance.
Images for APO N150 APO N150
Nilotinib
- Imprint
- APO N150 APO N150
- Strength
- 150 mg
- Color
- Red (red opaque body and red opaque cap)
- Shape
- Capsule/Oblong (hard gelatin capsule)
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
- National Drug Code (NDC)
- 60505-3801
Related images for "APO N150 APO N150"
More about nilotinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (40)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.